Salix Coronary Plaque vs CardioLogs ECG Analysis Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Salix Coronary Plaque

by Artrya Limited

CardioLogs ECG Analysis Platform

by CardioLogs (acquired by Philips in 2021)

AI Verdict

Tool A is designed for the structural assessment of coronary arteries, analyzing CCTA scans to detect and quantify plaque and stenosis for coronary artery disease diagnosis. Conversely, Tool B focuses on the electrical activity of the heart, utilizing AI to analyze ECG data from various devices for arrhythmia detection and diagnosis. While both are cloud-based AI tools in cardiology, they address different diagnostic needs and process distinct types of medical data.

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if your primary need is an AI-driven, near real-time assessment of coronary artery plaque and stenosis directly from CCTA scans. This tool is ideal for rapidly diagnosing coronary artery disease, quantifying calcifications, and identifying high-risk plaque features at the point of care.

View Salix Coronary Plaque →

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if you require medical-grade AI for the rapid and accurate analysis of ECG data from a wide range of cardiac monitoring devices. This platform is best suited for efficiently detecting and diagnosing various arrhythmias across different patient monitoring modalities, including Holter, smartwatches, and ECG patches.

View CardioLogs ECG Analysis Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Salix Coronary Plaque	CardioLogs ECG Analysis Platform
Pricing	Contact for pricing	Unknown
Deployment	Cloud	Cloud-based
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools offer strong usability features tailored to their specific domains. Tool A emphasizes near real-time, point-of-care assessment and integrated workflow management for CCTA analysis. Tool B highlights multi-device compatibility and EHR integration for ECG analysis, suggesting broad applicability and seamless data flow within their respective clinical contexts.

Clinical Value

Tie

Both tools offer significant clinical value by addressing critical diagnostic needs in cardiology with FDA-cleared, AI-powered analysis. Tool A provides detailed insights into coronary artery disease from CCTA, crucial for risk stratification. Tool B offers rapid and accurate arrhythmia detection from ECG data, vital for managing heart rhythm disorders.

Pricing & Value

Salix Coronary Plaque

While both require contacting sales for specific pricing, Tool A explicitly mentions its alignment with a US CPT reimbursement rate (US$950 per assessment). This provides a clear, tangible financial value proposition and a pathway for cost recovery for providers, which is a significant advantage in the US healthcare market.

Enterprise Readiness

CardioLogs ECG Analysis Platform

Tool B explicitly states HIPAA compliance, likely BAA, EHR system integration, and ISO/IEC 27001 certified AWS servers, demonstrating robust data security, privacy, and interoperability. Its acquisition by Philips further strengthens its enterprise-grade support and reliability compared to Tool A, which lacks these explicit details in the provided information.

Innovation

Salix Coronary Plaque

While both leverage AI innovatively, Tool A stands out for its advanced capability to not only detect and quantify coronary plaque but also identify specific high-risk plaque features (e.g., low-attenuation plaque, napkin-ring sign) from CCTA scans. This provides a deeper, more prognostic understanding of coronary artery disease beyond traditional stenosis assessment.

Support & Docs

CardioLogs ECG Analysis Platform

As a Philips solution, Tool B benefits from the extensive global support infrastructure, comprehensive documentation, and training resources typically provided by a major healthcare technology company. This offers a significant advantage in terms of reliability and ongoing assistance compared to a standalone company like Artrya.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Salix Coronary Plaque	CardioLogs ECG Analysis Platform
Product Name	Salix Coronary Plaque	CardioLogs ECG Analysis Platform
Company	Artrya Limited	Cardiologs Technologies (now part of Philips)
Description	FDA-cleared, AI-driven, web-based software that provides near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease.	Uses medical-grade AI and cloud technology for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis.
Primary Function	Coronary artery plaque and stenosis assessment from CCTA scans	ECG data analysis for arrhythmia detection
Key Features	AI-enabled CCTA analysis, Near real-time, point-of-care assessment, Detection and quantification of coronary plaque (atherosclerosis), Identification of high-risk plaque features, Stenosis assessment, Quantification of calcifications (calcium scoring), Integrated workflow management, Automated report generation (editable)	AI-Powered ECG Analysis (Deep Neural Networks), Cloud-Based Platform, Multi-Device Compatibility (Holter, smartwatches, ECG patches), Automated Arrhythmia Detection (e.g., AFib, VT), Customizable Reports, Integration with EHR Systems, Real-Time Monitoring/Analysis, Data Encryption & Secure Hosting (ISO/IEC 27001 certified AWS servers)

Videos

Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and CardioLogs ECG Analysis Platform.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of Salix Coronary Plaque versus CardioLogs ECG Analysis Platform?

Salix Coronary Plaque is designed for the near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. In contrast, the CardioLogs ECG Analysis Platform utilizes AI and cloud technology for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, primarily aiding physicians in arrhythmia detection and diagnosis.

What types of patient data do these platforms analyze?

Salix Coronary Plaque analyzes cardiac computed tomography angiography (CCTA) scans to detect and quantify coronary plaque and stenosis. The CardioLogs ECG Analysis Platform analyzes ECG data, compatible with various cardiac monitoring devices such as Holter monitors, smartwatches, and ECG patches.

How do the pricing and reimbursement models differ between the two tools?

Salix Coronary Plaque operates on a per-scan assessment model, with a stated US CPT reimbursement rate of US$950 per assessment. The CardioLogs ECG Analysis Platform uses a pay-per-ECG pricing model, regardless of the number of users.

What specific AI-driven insights do these tools provide to physicians?

Salix Coronary Plaque provides AI-enabled detection and quantification of coronary plaque, identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification, positive remodeling, napkin-ring sign), stenosis assessment, and quantification of calcifications (calcium scoring). CardioLogs ECG Analysis Platform offers AI-powered automated arrhythmia detection, including conditions like AFib and VT, from ECG data.

How do these platforms integrate into existing clinical workflows?

Salix Coronary Plaque offers integrated workflow management and automated, editable report generation, designed to streamline CCTA analysis and reporting. The CardioLogs ECG Analysis Platform provides integration with EHR systems and customizable reports, aiming to centralize and triage data efficiently.

What are the key differences in data security and compliance features?

CardioLogs ECG Analysis Platform explicitly states it is HIPAA compliant and uses ISO/IEC 27001 certified AWS servers for data encryption and secure hosting. While Salix Coronary Plaque is generally expected to adhere to healthcare AI standards in the US market, its provided information does not explicitly detail its specific HIPAA compliance or security certifications for the product itself.